Reaction of enzyme-bound 5-deazaflavin with peroxides. Pyrimidine ring contraction via an epoxide intermediate.
Reaction of peroxides with 5-deazaflavin bound to glucose oxidase, lactate oxidase, or D-amino acid oxidase results in the formation of 5-deazaflavin 4a, 5-epoxide. The reaction of D-amino acid oxidase with m-chloroperoxybenzoate is an exception since the reagent reacts rapidly with the protein moiety to form m-chlorobenzoate which then binds noncovalently near the unmodified coenzyme. Epoxide bound to glucose oxidase is converted to deazaFAD X X in a reaction similar to that observed previously with oxynitrilase and glycolate oxidase. With lactate oxidase the epoxide is quite stable in the absence of light. With D-amino acid oxidase, denaturation of the protein is accompanied by the release of the epoxide into solution where it decomposes in a manner similar to that observed with model epoxide compounds at neutral pH. Reaction of deazaFAD X X with phosphodiesterase and alkaline phosphatase yields deazariboflavin X X. The same compound has been formed in model studies by exposing 5-deazariboflavin 4a,5-epoxide to alkaline conditions. Structural studies indicate that this reaction involves contraction of the pyrimidine ring to yield 4-ribityl-6,7-dimethyloxazolo[ 4,5-b ]quinolin-2(4H)-one. Model reaction studies are consistent with a mechanism initiated by alkaline hydrolysis of the pyrimidine ring at position 4 followed by two additional steps which proceed at neutral pH. A similar mechanism for the enzyme reactions appears likely since analogous intermediates are detected in the glycolate oxidase and the model reactions. The results suggest that position 4 of the coenzyme in oxynitrilase, glycolate oxidase, and glucose oxidase must be accessible to solvent and that the protein moiety must facilitate the initial hydrolysis of the pyrimidine ring since the enzyme reactions occur at neutral pH. Failure to observe formation of deazaFMN X X with lactate oxidase is attributed, at least in part, to the inaccessibility of the pyrimidine ring to solvent.
D000818:Animals; D003605:D-Amino-Acid Oxidase / Q000378:metabolism*; D005415:Flavins / Q000378:metabolism*; D005949:Glucose Oxidase / Q000378:metabolism*; D007668:Kidney / Q000201:enzymology; D007700:Kinetics; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009161:Mycobacterium / Q000201:enzymology; D010088:Oxidoreductases / Q000378:metabolism*; D010545:Peroxides / Q000378:metabolism*; D011485:Protein Binding; D013053:Spectrophotometry; D013552:Swine
D005415:Flavins; D010545:Peroxides; C019319:5-deazaflavin; C038658:5-deazaflavin 4,5-epoxide; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D005949:Glucose Oxidase; C021497:lactate 2-monooxygenase; D003605:D-Amino-Acid Oxidase